The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment

COŞKUN B. N., Dizdar O. s., Korkmaz S., ULUKAYA E., EVRENSEL T.

Współczesna Onkologia, vol.23, no.4, pp.208-213, 2019 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.5114/wo.2019.91539
  • Journal Name: Współczesna Onkologia
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.208-213
  • Bursa Uludag University Affiliated: Yes


Aim of the study: To investigate the efficacy of evaluating prognosis and response to lung cancer treatment using M30 and M65 antigens, which are indicators of necrosis.